We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXSC
2751
DELISTED
POWERSHARES FUNDAMENTAL PURE SMALL CORE PORTFOLIO
PXSC
$2K ﹤0.01%
+52
New +$2K
BSQR
2752
DELISTED
BSQUARE Corporation
BSQR
$2K ﹤0.01%
429
-586
-58% -$3.25K
BZF
2753
DELISTED
WisdomTree Brazilian Real Strategy Fund
BZF
$2K ﹤0.01%
+100
New +$1.81K
ACNT icon
2754
Ascent Industries
ACNT
$137M
$1K ﹤0.01%
78
+41
+111% +$467
ANAB icon
2755
AnaptysBio
ANAB
$1.62B
$1K ﹤0.01%
+50
New +$1.17K
ARLP icon
2756
Alliance Resource Partners
ARLP
$3.26B
$1K ﹤0.01%
66
-634
-91% -$14.4K
ATEC icon
2757
Alphatec Holdings
ATEC
$1.42B
$1K ﹤0.01%
+246
New +$786
AXR icon
2758
AMREP Corp
AXR
$117M
$1K ﹤0.01%
150
-450
-75% -$2.94K
BBP icon
2759
Virtus Biotech ETF
BBP
$98.3M
$1K ﹤0.01%
+35
New +$1.28K
BHC icon
2760
Bausch Health
BHC
$2.21B
$1K ﹤0.01%
100
-1,034
-91% -$14.2K
BMVP icon
2761
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$106M
$1K ﹤0.01%
27
+24
+800% +$659
BRID icon
2762
Bridgford Foods
BRID
$57.1M
$1K ﹤0.01%
72
-336
-82% -$3.91K
CARV
2763
DELISTED
Carver Bancorp
CARV
$1K ﹤0.01%
236
-3,057
-93% -$10.2K
CCRN
2764
DELISTED
Cross Country Healthcare
CCRN
$1K ﹤0.01%
+73
New +$1.07K
CEE
2765
Central and Eastern Europe Fund
CEE
$137M
$1K ﹤0.01%
+43
New +$899
CHRD icon
2766
Chord Energy
CHRD
$7.46B
$1K ﹤0.01%
100
-71
-42% -$999
CORT icon
2767
Corcept Therapeutics
CORT
$11.7B
$1K ﹤0.01%
108
-6,245
-98% -$54.8K
CRD.A icon
2768
Crawford & Co Class A
CRD.A
$625M
$1K ﹤0.01%
148
-3,402
-96% -$29.6K
CRT
2769
Cross Timbers Royalty Trust
CRT
$60.7M
$1K ﹤0.01%
100
-100
-50% -$1.67K
CSPI icon
2770
CSP Inc
CSPI
$83.2M
$1K ﹤0.01%
256
+56
+28% +$283
CZNC icon
2771
Citizens & Northern Corp
CZNC
$453M
$1K ﹤0.01%
50
-1,848
-97% -$44.7K
CZR icon
2772
Caesars Entertainment
CZR
$6.12B
$1K ﹤0.01%
+36
New +$607
DAC icon
2773
Danaos Corp
DAC
$2.61B
$1K ﹤0.01%
39
+21
+117% +$687
DENN
2774
DELISTED
Denny's
DENN
$1K ﹤0.01%
100
-1,949
-95% -$24.2K
DEUS icon
2775
Xtrackers Russell US Multifactor ETF
DEUS
$303M
$1K ﹤0.01%
+22
New +$618

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.